Skip to Main Content

Paper Details

A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs.
Nat Biotechnol
17
2022
Author NameAffiliation
James E KorkolaOHSU Center for Spatial Systems Biomedicine
James E KorkolaKnight Cancer Institute, Oregon Health & Science University
Laura M HeiserOHSU Center for Spatial Systems Biomedicine
Laura M HeiserKnight Cancer Institute, Oregon Health & Science University
Laura M HeiserOHSU Center for Spatial Systems Biomedicine
Laura M HeiserKnight Cancer Institute, Oregon Health & Science University
Gordon B MillsOregon Health & Science University
Gordon B MillsOregon Health & Science University
Joe W GrayOHSU Center for Spatial Systems Biomedicine
Joe W GrayKnight Cancer Institute, Oregon Health & Science University
Joe W GrayOHSU Center for Spatial Systems Biomedicine
Joe W GrayKnight Cancer Institute, Oregon Health & Science University
  • 1 - 12

Datasets

Release 1.2